(Q34521815)

2 August 2017

1 reference

title

Basic mechanisms of psychotropic drugs (English)

1 reference

2 August 2017

Ulrich Ebert

1

1 reference

2 August 2017

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

43 Suppl 2

1 reference

2 August 2017

page(s)

2-7

1 reference

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Dopamine, the prefrontal cortex and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

The cerebral cortex: a case for a common site of action of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

On the slowness of action of tricyclic antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Development of β-adrenergic receptor subsensitivity by antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Antidepressants: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Inositol phosphates and cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Loss of a prolyl oligopeptidase confers resistance to lithium by elevation of inositol (1,4,5) trisphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Bipolar depression: pharmacotherapy and related therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Benzodiazepine receptor: demonstration in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Benzodiazepine receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

GABAA receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Which GABAA-receptor subtypes really occur in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

The benzodiazepine binding site of GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

Molecular and neuronal substrate for the selective attenuation of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2002.043S2002.X

10.1046/J.1528-1157.2002.043S2002.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference